Maher J - Search Results

1

Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ductal adenocarcinoma.

Cutmore LC, Brown NF, Raj D, Chauduri S, Wang P, Maher J, Wang Y, Lemoine NR, Marshall JF. Cutmore LC, et al. Among authors: maher j. Pancreatology. 2020 Apr;20(3):394-408. doi: 10.1016/j.pan.2020.02.006. Epub 2020 Feb 15. Pancreatology. 2020. PMID: 32173257 Review.

2

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.

Whilding LM, Parente-Pereira AC, Zabinski T, Davies DM, Petrovic RMG, Kao YV, Saxena SA, Romain A, Costa-Guerra JA, Violette S, Itamochi H, Ghaem-Maghami S, Vallath S, Marshall JF, Maher J. Whilding LM, et al. Among authors: maher j. Mol Ther. 2017 Jan 4;25(1):259-273. doi: 10.1016/j.ymthe.2016.10.012. Epub 2017 Jan 4. Mol Ther. 2017. PMID: 28129120 Free PMC article.

3

Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.

Hodgins NO, Al-Jamal WT, Wang JT, Klippstein R, Costa PM, Sosabowski JK, Marshall JF, Maher J, Al-Jamal KT. Hodgins NO, et al. Among authors: maher j. J Control Release. 2017 Jun 28;256:141-152. doi: 10.1016/j.jconrel.2017.04.025. Epub 2017 Apr 18. J Control Release. 2017. PMID: 28432037 Free PMC article.

4

Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma.

Yazdanifar M, Zhou R, Grover P, Williams C, Bose M, Moore LJ, Wu ST, Maher J, Dreau D, Mukherjee AP. Yazdanifar M, et al. Among authors: maher j. Cells. 2019 Sep 11;8(9):1070. doi: 10.3390/cells8091070. Cells. 2019. PMID: 31514488 Free PMC article.

5

Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells.

Alrifai D, Sarker D, Maher J. Alrifai D, et al. Among authors: maher j. Immunopharmacol Immunotoxicol. 2016;38(1):50-60. doi: 10.3109/08923973.2015.1100204. Epub 2015 Oct 16. Immunopharmacol Immunotoxicol. 2016. PMID: 26473647

6

CAR T-cell immunotherapy: The path from the by-road to the freeway?

Whilding LM, Maher J. Whilding LM, et al. Among authors: maher j. Mol Oncol. 2015 Dec;9(10):1994-2018. doi: 10.1016/j.molonc.2015.10.012. Epub 2015 Oct 23. Mol Oncol. 2015. PMID: 26563646 Free PMC article. Review.

7

The integrin αvβ6: a novel target for CAR T-cell immunotherapy?

Whilding LM, Vallath S, Maher J. Whilding LM, et al. Among authors: maher j. Biochem Soc Trans. 2016 Apr 15;44(2):349-55. doi: 10.1042/BST20150249. Biochem Soc Trans. 2016. PMID: 27068939 Review.

8

New Developments in Imaging Cell-Based Therapy.

Martinez O, Sosabowski J, Maher J, Papa S. Martinez O, et al. Among authors: maher j. J Nucl Med. 2019 Jun;60(6):730-735. doi: 10.2967/jnumed.118.213348. Epub 2019 Apr 12. J Nucl Med. 2019. PMID: 30979822 Free PMC article. Review.

9

Novel approaches to promote CAR T-cell function in solid tumors.

Hull CM, Maher J. Hull CM, et al. Among authors: maher j. Expert Opin Biol Ther. 2019 Aug;19(8):789-799. doi: 10.1080/14712598.2019.1614164. Epub 2019 May 10. Expert Opin Biol Ther. 2019. PMID: 31038366 Review.

10

Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies.

Mazza R, Maher J. Mazza R, et al. Among authors: maher j. Arch Immunol Ther Exp (Warsz). 2021 Dec 12;70(1):2. doi: 10.1007/s00005-021-00640-7. Arch Immunol Ther Exp (Warsz). 2021. PMID: 34897554 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,268 results

Search Page

Filters